Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.
Surprising findings from the largest study to date investigating the genetics of osteoporosis and fracture risk.
Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.
Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
A Quest Diagnostics study sheds light on Medicare patients with multiple chronic conditions and the top three care gaps.
A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.
A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.
A new study investigates the impact of interruptions in the emergency room. Here are the disturbing results
The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
A new report is making some healthcare executives a bit more optimistic about efforts to curb the opioid epidemic. Find out why.